-
What to do when an exposé tanks your stock? For J&J, you go direct to consumers
fiercepharma
January 03, 2019
Johnson & Johnson is taking its baby powder case to consumers. A new print and online ad will begin running this week contending “Our talc is safe” and asking people to read the scientific evidence for themselves.
-
J&J stock tumbles after Reuters reports it hid asbestos in talc
fiercepharma
January 02, 2019
After a series of ups and downs in defense of its flagship Johnson’s Baby Powder, Johnson & Johnson hit renewed scrutiny Friday as Reuters reported the drugmaker knew for decades its talc powder contained cancer-causing asbestos.
-
Talc lawyer says J&J's multibillion-dollar stock woes make settling look like a better deal
fiercepharma
December 25, 2018
What's bad for Johnson & Johnson shares is good for the trial lawyer leading the charge in the talc liability litigation—or so the lawyer says, as J&J scrambles to contain the damage from a bombshell Reuters report Friday.
-
Talc lawyer says J&J's multibillion-dollar stock woes make settling look like a better deal
pharmatimes
December 20, 2018
What's bad for Johnson & Johnson shares is good for the trial lawyer leading the charge in the talc liability litigation—or so the lawyer says, as J&J scrambles to contain the damage from a bombshell Reuters report Friday.
-
J&J stock tumbles after Reuters report on asbestos in talc
fiercepharma
December 19, 2018
After a series of ups and downs in defense of its flagship Johnson’s Baby Powder, Johnson & Johnson hit renewed scrutiny Friday as Reuters reported the drugmaker knew for decades its talc powder contained cancer-causing asbestos.
-
What to do when an exposé tanks your stock? For J&J, you go direct to consumers
fiercepharma
December 19, 2018
Johnson & Johnson is taking its baby powder case to consumers. A new print and online ad will begin running this week contending “Our talc is safe” and asking people to read the scientific evidence for themselves.